MQCKXANXFRGFND-CGIARSFXSA-N manufacturers
|
| | MQCKXANXFRGFND-CGIARSFXSA-N Basic information |
| Product Name: | MQCKXANXFRGFND-CGIARSFXSA-N | | Synonyms: | MQCKXANXFRGFND-CGIARSFXSA-N;Resolvin D2 methyl ester;4,8,10,12,14,19-Docosahexaenoic acid, 7,16,17-trihydroxy-, methyl ester, (4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-;Resveratrol-2',3',5',6'-d4 3-Sulfate Ester Sodium Salt | | CAS: | 810668-53-2 | | MF: | C23H34O5 | | MW: | 390.51 | | EINECS: | | | Product Categories: | | | Mol File: | 810668-53-2.mol |  |
| | MQCKXANXFRGFND-CGIARSFXSA-N Chemical Properties |
| Boiling point | 562.1±50.0 °C(Predicted) | | density | 1.064±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 0.05 mg/ml | | pka | 13.38±0.20(Predicted) |
| | MQCKXANXFRGFND-CGIARSFXSA-N Usage And Synthesis |
| Description | Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. It evokes diverse anti-inflammatory effects which may mediate the resolution of inflammation. RvD2 methyl ester is a methyl ester version of the free acid which may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. The methyl ester moiety is susceptible to cleavage by intracellular esterases, leaving the free acid. | | Uses | Resolvin D2 Methyl Ester acts as a lipophilic prodrug form while in the free acid state which alters its distribution and pharmacokinetic properties. |
| | MQCKXANXFRGFND-CGIARSFXSA-N Preparation Products And Raw materials |
|